In murine and human gliomas, both malignant cells and tumor-infiltrating myeloid cells have been found to upregulate the expression of Arg1, and the resulting changes in L-arginine metabolism are a critical mechanism contributing to immune suppression [62]. Here, ARG1 is linked to glioma.